Pricing

Log inSign up

Biohaven Pharmaceuticals

6 followers

‌

Biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system.

Industries

Biotechnology

Headquarters

New Haven, United States

Employees

501-1,000

Links

Org chart

VC
Vlad Coric
Chairman & CEO
Collapse
George Clark
VP, Chief Accounting Officer
Robert Croop
Chief Development Officer, Neurology
Bruce D. Car
Chief Scientific Officer
Tova Gardin
Chief Translational Officer
Matthew Buten
Chief Financial Officer
St John Donnie McGrath
Chief of Corporate Strategy & Business Development
Warren Volles
General Counsel & Chief Legal Officer
Cliff Bechtold
President & GM, Biohaven Ireland, Chief Compliance Officer
Michael Bozik
President, Ion Channel Research & Development
David Weaver
SVP, Neuroscience & Pharmacology
Kimberly Gentile
SVP, Clinical Operations
David Stock
VP, Biostatistics
Wes Kazmierski
Senior Director, Chemistry
Elyse Stock
Senior Scientific Advisor
JE
Jim Engelhart
Chief Financial Officer
Amer Syed
National Speaker

Board & advisors

Michael T. Heffernan
Lead Independent Director
Gregory H. Bailey
Director
John W. Childs
Director
Robert J. Hugin
Director
Irina A. Antonijevic
Director
Gregory Hebrank
Advisor, Clinical & Discovery

Teams

+38

Leadership Team

42 people · 0 jobs

+35

Clinical Operations Team

39 people · 0 jobs

+25

Research and Development Team

29 people · 0 jobs

+3

Legal and Compliance Team

7 people · 0 jobs

Offices

Similar companies

GRAIL

27 followers

Organogenesis

4 followers

Veracyte

4 followers

Molecular Devices

2 followers

Amicus Therapeutics

4 followers

AtriCure

4 followers

Gilead Sciences

157 followers

Regeneron

124 followers

Illumina

78 followers

Agilent Technologies

78 followers

Verily Life Sciences

45 followers

Explore companies